The Management of Poststroke Thalamic Pain: Update in Clinical Practice

Poststroke thalamic pain (PS-TP), a type of central poststroke pain, has been challenged to improve the rehabilitation outcomes and quality of life after a stroke. It has been shown in 2.7–25% of stroke survivors; however, the treatment of PS-TP remains difficult, and in majority of them it often fa...

Full description

Bibliographic Details
Main Author: Songjin Ri
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/6/1439
_version_ 1797488265843965952
author Songjin Ri
author_facet Songjin Ri
author_sort Songjin Ri
collection DOAJ
description Poststroke thalamic pain (PS-TP), a type of central poststroke pain, has been challenged to improve the rehabilitation outcomes and quality of life after a stroke. It has been shown in 2.7–25% of stroke survivors; however, the treatment of PS-TP remains difficult, and in majority of them it often failed to manage the pain and hypersensitivity effectively, despite the different pharmacotherapies as well as invasive interventions. Central imbalance, central disinhibition, central sensitization, other thalamic adaptative changes, and local inflammatory responses have been considered as its possible pathogenesis. Allodynia and hyperalgesia, as well as the chronic sensitization of pain, are mainly targeted in the management of PS-TP. Commonly recommended first- and second-lines of pharmacological therapies, including traditional medications, e.g., antidepressants, anticonvulsants, opioid analgesics, and lamotrigine, were more effective than others. Nonpharmacological interventions, such as transcranial magnetic or direct current brain stimulations, vestibular caloric stimulation, epidural motor cortex stimulation, and deep brain stimulation, were effective in some cases/small-sized studies and can be recommended in the management of therapy-resistant PS-TP. Interestingly, the stimulation to other areas, e.g., the motor cortex, periventricular/periaqueductal gray matter, and thalamus/internal capsule, showed more effect than the stimulation to the thalamus alone. Further studies on brain or spinal stimulation are required for evidence.
first_indexed 2024-03-10T00:00:40Z
format Article
id doaj.art-b3edc8a34944493887217c2417fe91e3
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T00:00:40Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-b3edc8a34944493887217c2417fe91e32023-11-23T16:18:12ZengMDPI AGDiagnostics2075-44182022-06-01126143910.3390/diagnostics12061439The Management of Poststroke Thalamic Pain: Update in Clinical PracticeSongjin Ri0Department for Neurology, Meoclinic, Berlin, Friedrichstraße 71, 10117 Berlin, GermanyPoststroke thalamic pain (PS-TP), a type of central poststroke pain, has been challenged to improve the rehabilitation outcomes and quality of life after a stroke. It has been shown in 2.7–25% of stroke survivors; however, the treatment of PS-TP remains difficult, and in majority of them it often failed to manage the pain and hypersensitivity effectively, despite the different pharmacotherapies as well as invasive interventions. Central imbalance, central disinhibition, central sensitization, other thalamic adaptative changes, and local inflammatory responses have been considered as its possible pathogenesis. Allodynia and hyperalgesia, as well as the chronic sensitization of pain, are mainly targeted in the management of PS-TP. Commonly recommended first- and second-lines of pharmacological therapies, including traditional medications, e.g., antidepressants, anticonvulsants, opioid analgesics, and lamotrigine, were more effective than others. Nonpharmacological interventions, such as transcranial magnetic or direct current brain stimulations, vestibular caloric stimulation, epidural motor cortex stimulation, and deep brain stimulation, were effective in some cases/small-sized studies and can be recommended in the management of therapy-resistant PS-TP. Interestingly, the stimulation to other areas, e.g., the motor cortex, periventricular/periaqueductal gray matter, and thalamus/internal capsule, showed more effect than the stimulation to the thalamus alone. Further studies on brain or spinal stimulation are required for evidence.https://www.mdpi.com/2075-4418/12/6/1439thalamic paincentral painstrokepainpoststroke thalamic paincentral poststroke pain
spellingShingle Songjin Ri
The Management of Poststroke Thalamic Pain: Update in Clinical Practice
Diagnostics
thalamic pain
central pain
stroke
pain
poststroke thalamic pain
central poststroke pain
title The Management of Poststroke Thalamic Pain: Update in Clinical Practice
title_full The Management of Poststroke Thalamic Pain: Update in Clinical Practice
title_fullStr The Management of Poststroke Thalamic Pain: Update in Clinical Practice
title_full_unstemmed The Management of Poststroke Thalamic Pain: Update in Clinical Practice
title_short The Management of Poststroke Thalamic Pain: Update in Clinical Practice
title_sort management of poststroke thalamic pain update in clinical practice
topic thalamic pain
central pain
stroke
pain
poststroke thalamic pain
central poststroke pain
url https://www.mdpi.com/2075-4418/12/6/1439
work_keys_str_mv AT songjinri themanagementofpoststrokethalamicpainupdateinclinicalpractice
AT songjinri managementofpoststrokethalamicpainupdateinclinicalpractice